Prothena reported $581.41M in Assets for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Acadia Pharmaceuticals ACAD:US $ 624.25M 75.87M
Agios Pharmaceuticals AGIO:US $ 1335.86M 101.88M
Akebia Therapeutics AKBA:US $ 535.36M 9.81M
ALKERMES ALKS:US $ 1977.84M 46.64M
Alnylam Pharmaceuticals ALNY:US $ 3433.54M 209.76M
Amgen AMGN:US $ 59196M 1969M
Biogen BIIB:US $ 23614.4M 262.9M
Biomarin Pharmaceutical BMRN:US $ 6062.71M 59.38M
Bluebird Bio BLUE:US $ 491.07M 102.72M
Exelixis EXEL:US $ 2654.12M 37.88M
Intercept Pharmaceuticals ICPT:US $ 503.36M 23.67M
Intra Cellular Therapies ITCI:US $ 868.58M 378.66M
IONIS PHARMACEUT IONS:US $ 2519.09M 92.6M
Macrogenics MGNX:US $ 271.44M 63.8M
Nektar Therapeutics NKTR:US $ 1024.12M 93.07M
Prothena PRTA:US $ 581.41M 27.95M
Regeneron Pharmaceuticals REGN:US $ 26348.7M 913.9M
Seattle Genetics SGEN:US $ 3616.69M 102.91M
Ultragenyx Pharmaceutical RARE:US $ 1384.03M 138.37M
Vertex Pharmaceuticals VRTX:US $ 14256.1M 823.6M
Vital Therapies VTL:US $ 149.92M 10.82M
Xoma XOMA:US $ 159.16M 7.4M
YTE INCY:US $ 5054.22M 120.87M